Apimeds Pharmaceuticals US (APUS) Retained Earnings (2023 - 2025)
Apimeds Pharmaceuticals US's (APUS) quarterly Retained Earnings came in at -$10.4 million in Q4 2025, down 136.64% YoY from $28.4 million in Q4 2024, and down 12.51% on a QoQ basis from -$9.2 million in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Retained Earnings (2023 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US (APUS) has 3 years of Retained Earnings data on file, last reported at -$10.4 million in Q4 2025.
- Quarterly Retained Earnings fell 136.64% year-over-year to -$10.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$10.4 million (down 136.64% YoY) and the FY2025 annual result came in at -$10.4 million, down 136.64% from the prior year.
- Retained Earnings eased to -$10.4 million in Q4 2025, from -$9.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $3.0 million in Q4 2023 to a low of -$10.4 million in Q4 2025.
- A 3-year average of -$5.6 million and a median of -$6.1 million in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings tumbled 248.64% — and 2025, when it tumbled 136.64%.
- Tracing APUS's Retained Earnings over 3 years: stood at $3.0 million in 2023, then plunged by 248.64% to -$4.4 million in 2024, then plunged by 136.64% to -$10.4 million in 2025.
- The last three Retained Earnings figures came in at -$10.4 million (Q4 2025), -$9.2 million (Q3 2025), and -$7.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.36 Bn | 43.40 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.76 Bn | 40.11 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.39 Bn | 30.71 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.45 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.87 Bn | 17.99 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.64 Bn | 15.25 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.75 Bn |
| 10 | Apimeds Pharmaceuticals US | 8.55 Mn | 8.55 Mn | - | 168.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.39 Mn |
| Sep 30, 2025 | -9.24 Mn |
| Jun 30, 2025 | -7.46 Mn |
| Mar 31, 2025 | -4.79 Mn |
| Dec 31, 2024 | -4.39 Mn |
| Dec 31, 2023 | 2.95 Mn |